Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes

  • Thomas Westergard,
  • Reza Salari,
  • Joseph V. Martin,
  • Grace Brannigan

Notice of Republication

This article was republished on October 21, 2015, to correct the name of the thyroid hormone in the title; “L-3,5,4'-Triiodothyronine” was corrected to read “L-3,5,3'-Triiodothyronine.” Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting Information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0142514.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0142514.s002

(PDF)

Reference

  1. 1. Westergard T, Salari R, Martin JV, Brannigan G (2015) Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes. PLoS ONE 10(9): e0139072. pmid:26421724

Citation: Westergard T, Salari R, Martin JV, Brannigan G (2015) Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes. PLoS ONE 10(11): e0142514. https://doi.org/10.1371/journal.pone.0142514

Published: November 3, 2015

Copyright: © 2015 Westergard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited